-
-
- Aug 25/26
Two decades of induced pluripotent stem cells: From pluripotency to reprogramming - Aug 24/26
Safety concerns spur FDA to again halt testing of Regenxbio gene therapy - Aug 23/26
Weekly reads: Heidi Overton FDA commish nominee, NASA stem cells, aged brain organoids, cautious Nature iPS cell editorial - Aug 20/26
Ultragenyx wins FDA approval for first treatment targeting root cause of GSDIa - Aug 20/26
The BioPharm Brief: Rare Disease, New Options - Aug 19/26
3D-printed spheroids support the regeneration of bone tissue - Aug 19/26
Red blood cells inspire next-generation therapeutic nanocarriers - Aug 18/26
Red blood cell-inspired carriers show promise for gene therapy delivery - Aug 18/26
Researchers develop invisible cell armour for safer diabetes treatment - Aug 18/26
Spatial biology in infectious disease and emerging fields - Aug 17/26
After two undisclosed gene therapy deaths, can China’s alternative regulatory path still be trusted? - Aug 17/26
Dongguk University researchers develop innovative electromagnetically controllable gene switch - Aug 17/26
Red blood ells inspire next-generation nanocarriers for targeted therapies - Aug 17/26
New imaging technology tracks cancer from the whole body to single cells - Aug 17/26
This Week’s CGT News: T-cell therapy clears pediatric solid tumour - Aug 15/26
DUSP4 boosts antitumour CD8+ T cells, CAR-T efficacy in colorectal cancer mice - Aug 14/26
First human trials of designer protein therapies stun US neuroscientists - Aug 14/26
Fate Therapeutics initiates potentially registrational trial of off-the-shelf CAR T-cell therapy FT819 for lupus nephritis - Aug 14/26
A genomics library for the AI era - Aug 14/26
Cell ‘invisibility cloaks’ could offer side-effect-free diabetes treatment - Aug 13/26
Meis2 gene identified as potential therapeutic target for neurodevelopmental disorders - Aug 13/26
Editorial: Can iPS cells clear the barriers to practical use? - Aug 11/26
Lorenz Studer begins Presidency of International Society for Stem Cell Research - Aug 10/26
This Week’s CGT News: In vivo CAR T draws major investment - Aug 10/26
Building scalable, reliable AAV gene therapy manufacturing - Aug 9/26
Weekly reads: DOJ claims $95M perinatal tissue fraud, 6-year peptide prison term, ALS patient story, worrisome MRT clinics - Aug 7/26
Gene therapy may prevent dilated intercellular spaces linked to acid reflux disease - Aug 6/26
Advancements in iPSC technology: Enhancing precision medicine and therapeutics - Aug 6/26
Teaching lab-grown liver cells to grow up: how AI and genetics are transforming stem cell research - Aug 6/26
Prime editing precisely corrects GJB2 c.235delC mutation in laboratory cells - Aug 6/26
Shuttling gene activating proteins through packed histones treats neurodegenerative disease - Aug 5/26
Chaotic adcomms threaten to derail FDA’s bid to renew trust after Makary, Prasad - Aug 5/26
How scientists hope to retrain the immune system after an organ transplant - Aug 5/26
Allogeneic immunotherapy harnesses donor cells to fight disease - Aug 5/26
Engineered spinal interneurons show promise for repairing spinal cord injuries - Aug 5/26
Soluble signals released by neighbouring cells direct how the human kidney is built - Aug 5/26
Midweek news: another FDA warning & Florida state stem cell law problems already - Aug 5/26
Artificial cells reveal how living cells take shape through giant blebs - Aug 5/26
Virus-like particles deliver gene-editing tools into Duchenne mouse model - Aug 4/26
How CRISPR-edited donor islet cells are opening a path toward a functional cure for type 1 diabetes - Aug 4/26
How transposable elements adapt in clinically important adult stem cells - Aug 4/26
AI framework aids target discovery for CAR T cell therapy - Aug 3/26
UCLA scientists build ‘cell villages’ to map the genetics of brain cell fitness - Aug 3/26
Biogen’s Salanersen shows potential to address unmet needs in spinal muscular atrophy - Aug 3/26
This Week’s CGT News: Gene-Editing Trial Death Raises Concerns - Aug 3/26
Researchers identify immune “off switch” exploited by cancer cells - Aug 2/26
Weekly reads: FDA warning, Capricor pub vs. AdCom, stem cells can count, hydra regeneration - Jul 30/26
FDA AdCom shuns Capricor’s DMD cell therapy amid data dispute - Jul 30/26
The next phase of diabetes cell therapy and islet transplantation - Jul 30/26
J&J secures right to take the helm in up to $925M Sail CAR T pact - Jul 30/26
Musings from The Power List: Claudia Zylberberg - Jul 30/26
Scientists at UMass Chan Medical School develop microRNA-based gene therapy that halts ALS progression in mice - Jul 29/26
Teen walks independently after treatment targets the genetic root of epilepsy - Jul 29/26
Donor cord blood composition may influence CAR NK cell therapy outcomes - Jul 29/26
The BioPharm Brief: Designations, Decisions, and Data - Jul 28/26
Phenotypic and functional characterization of CAR-T cells to support robust cell therapy research - Jul 28/26
Leadership changes afoot at two CGT biotechs - Jul 28/26
Blood must flow: How pushing and pulling forces shape our blood vessels - Jul 27/26
Relapsed or refractory multiple myeloma: Early-phase trial investigates novel bispecific antibody - Jul 27/26
This Week’s CGT News: Off-the-shelf CAR T tackles kidney cancer - Jul 26/26
Weekly reads: MYC phosphorylation, reverse protein aging, mitochondria don’t like space, that peptide committee - Jul 26/26
HMN 2026: How sound waves guide cultured cells to form vessel-like networks within one week - Jul 24/26
Mass-producible immune cells kill patient-derived colorectal tumours in mice - Jul 23/26
Four takeaways from our investigation into a hidden gene-editing death - Jul 21/26
Canada has the science. Does it have the strategy to be a life sciences power? - Jul 21/26
Stem cell therapy for GA shows early evidence of vision gains, retina preservation - Jul 21/26
Personalized gene therapy helps teen with rare form of severe epilepsy walk independently - Jul 20/26
This Week’s CGT News: First-in-human diabetes cell therapy - Jul 20/26
Kolon’s cell-based gene therapy fails phase 3 osteoarthritis trial - Jul 20/26
Scalable cell therapy manufacturing: Shifting from research to GMP - Jul 16/26
Human embryo models (SCBEM) are powerful but probably won’t get a Nobel; lessons about rewards in science - Jul 16/26
New technology identifies differences and conditions in culture media for cell biomanufacturing - Jul 15/26
Immune cells use previously unknown pathway to eliminate AML - Jul 15/26
Gene therapy reverses fragile X traits in preclinical study - Jul 15/26
Sound waves guide formation of engineered tissues - Jul 14/26
CAR T cell therapy shows promise for myelofibrosis - Jul 14/26
Steer Bio targets lymphedema with regenerative cell therapy platform - Jul 14/26
Novel CAR T cell therapy offers promising option for hard-to-treat kidney cancer - Jul 14/26
The BioPharm Brief: Reduction, relief and reach - Jul 14/26
Let’s stop treating allogeneic cell therapy as one thing - Jul 13/26
This week’s CGT news: Radiopharmaceutical boosts CAR T - Jul 13/26
Universal 6iL/E4 system enables stem cell growth across mammals - Jul 13/26
In vivo CAR T: A new route to treating autoimmune disease - Jul 13/26
The first human trial to reverse aging just Got FDA clearance: What epigenetic reprogramming actually is - Jul 13/26
Smart cellular bricks: When physical modules learn to recognize and repair themselves - Jul 12/26
Weekly reads: Colossal Bio & Trump admin partnership, FDA commish finalists, appetite-regulating neurons - Jul 10/26
First clinical trial of stem cell therapy for Huntington’s disease announced - Jul 9/26
New genetic screen advances understanding of human development - Jul 9/26
RoslinCT partners with BlueRock Therapeutics to expand access to clinical-grade stem cell lines - Jul 8/26
Endless supply of cancer-fighting immune cells unlocked by USC scientists - Jul 8/26
Novel strategy can make stem cell transplants safer - Jul 8/26
New gene therapy strategy uses the brain’s own glymphatic transport system for drug delivery - Jul 7/26
Why Canada needs to build its biomanufacturing capacity - Jul 7/26
Breakthrough diabetes treatment reprograms the immune system instead of replacing insulin - Jul 7/26
This Week’s CGT News: First Treg Therapy Approved - Jul 7/26
UCLA research team awarded millions to bring new MS therapy to trial - Jul 7/26
Two MSL faculty awarded 2026 NSERC Funding
- Aug 25/26
-
